{"abstract":"The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing mitragynine pseudoindoxyl, MGM-15, and MGM-16 in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.","action":"Temporary amendment; temporary scheduling order.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/08/26/2026-17429.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"1308","title":21}],"citation":"91 FR 54948","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This temporary order is effective August 26, 2026, until August 26, 2028. If this order is extended or made permanent, DEA will publish a document in the Federal Register.","disposition_notes":null,"docket_ids":["Docket No. DEA-1644"],"dockets":[{"supporting_documents":[{"title":"DEA-1644 Three Factor Analysis for Temporary Control of Mitragynine pseudoindoxyl MGM-15 and MGM-16","document_id":"DEA-2026-1189-0003"},{"title":"7-OH Mitragynine-related substances DEA-1644 HHS Letter  to DEA","document_id":"DEA-2026-1189-0002"}],"agency_name":"DEA","documents":[{"comment_count":0,"comment_start_date":"2026-08-26","updated_at":"2026-08-26T09:56:56.742-04:00","comment_url":"https://www.regulations.gov/commenton/DEA-2026-1189-0004","allow_late_comments":false,"id":"DEA-2026-1189-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"DEA-2026-1189","title":"Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (DEA1644)"}],"document_number":"2026-17429","effective_on":"2026-08-26","end_page":54956,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/08/26/2026-17429.xml","html_url":"https://www.federalregister.gov/documents/2026/08/26/2026-17429/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-17429?publication_date=2026-08-26","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-08-26/2026-17429/mods.xml","not_received_for_publication":null,"page_length":9,"page_views":{"count":5701,"last_updated":"2026-09-20 18:15:07 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-08-26/pdf/2026-17429.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-17429.pdf?1787602521","publication_date":"2026-08-26","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/08/26/2026-17429.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"DEA-1644 Three Factor Analysis for Temporary Control of Mitragynine pseudoindoxyl MGM-15 and MGM-16","document_id":"DEA-2026-1189-0003"},{"title":"7-OH Mitragynine-related substances DEA-1644 HHS Letter  to DEA","document_id":"DEA-2026-1189-0002"}],"comments_count":0,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2026-1189","supporting_documents_count":2,"docket_id":"DEA-2026-1189","document_id":"DEA-2026-1189-0004","regulation_id_number":null,"title":"Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (DEA1644)","checked_regulationsdotgov_at":"2026-08-27T16:55:06Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":54948,"subtype":null,"title":"Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I","toc_doc":"Temporary Placement of Mitragynine Pseudoindoxyl, MGM15, and MGM16 in Schedule I","toc_subject":"Schedules of Controlled Substances","topics":["Administrative practice and procedure","Drug traffic control","Reporting and recordkeeping requirements"],"type":"Rule","volume":91}